Single Donor Human Red Blood Cells from Innovative Research was used in the following study:
In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K
Sven-Ulrik Gorr, Craig M. Flory, Robert J. Schumacher
PLOS ONE
May 9, 2019
“…Traditional antibiotics are losing their effectiveness due to increasing bacterial resistance. Combined with a decreasing pipeline of novel drugs, it is feared that many critical infections will be difficult or impossible to treat in the near future. …Human red blood cells (RBC) (single donor) were obtained from Innovative Research (Novi, MI)…”
